These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 15004163)

  • 1. Nasal Flt3 ligand cDNA elicits CD11c+CD8+ dendritic cells for enhanced mucosal immunity.
    Kataoka K; McGhee JR; Kobayashi R; Fujihashi K; Shizukuishi S; Fujihashi K
    J Immunol; 2004 Mar; 172(6):3612-9. PubMed ID: 15004163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel adenovirus expressing Flt3 ligand enhances mucosal immunity by inducing mature nasopharyngeal-associated lymphoreticular tissue dendritic cell migration.
    Sekine S; Kataoka K; Fukuyama Y; Adachi Y; Davydova J; Yamamoto M; Kobayashi R; Fujihashi K; Suzuki H; Curiel DT; Shizukuishi S; McGhee JR; Fujihashi K
    J Immunol; 2008 Jun; 180(12):8126-34. PubMed ID: 18523277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RANTES potentiates antigen-specific mucosal immune responses.
    Lillard JW; Boyaka PN; Taub DD; McGhee JR
    J Immunol; 2001 Jan; 166(1):162-9. PubMed ID: 11123289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of mucosal adjuvants on antigen passage and CD4+ T cell activation during the primary response to airborne allergen.
    Wikstrom ME; Batanero E; Smith M; Thomas JA; von Garnier C; Holt PG; Stumbles PA
    J Immunol; 2006 Jul; 177(2):913-24. PubMed ID: 16818746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective mucosal immunity in aging is associated with functional CD4+ T cells in nasopharyngeal-associated lymphoreticular tissue.
    Hagiwara Y; McGhee JR; Fujihashi K; Kobayashi R; Yoshino N; Kataoka K; Etani Y; Kweon MN; Tamura S; Kurata T; Takeda Y; Kiyono H; Fujihashi K
    J Immunol; 2003 Feb; 170(4):1754-62. PubMed ID: 12574339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The nasal dendritic cell-targeting Flt3 ligand as a safe adjuvant elicits effective protection against fatal pneumococcal pneumonia.
    Kataoka K; Fujihashi K; Oma K; Fukuyama Y; Hollingshead SK; Sekine S; Kawabata S; Ito HO; Briles DE; Oishi K
    Infect Immun; 2011 Jul; 79(7):2819-28. PubMed ID: 21536790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphotactin acts as an innate mucosal adjuvant.
    Lillard JW; Boyaka PN; Hedrick JA; Zlotnik A; McGhee JR
    J Immunol; 1999 Feb; 162(4):1959-65. PubMed ID: 9973465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A combination of Flt3 ligand cDNA and CpG ODN as nasal adjuvant elicits NALT dendritic cells for prolonged mucosal immunity.
    Fukuiwa T; Sekine S; Kobayashi R; Suzuki H; Kataoka K; Gilbert RS; Kurono Y; Boyaka PN; Krieg AM; McGhee JR; Fujihashi K
    Vaccine; 2008 Sep; 26(37):4849-59. PubMed ID: 18625280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral tolerance revisited: prior oral tolerization abrogates cholera toxin-induced mucosal IgA responses.
    Kato H; Fujihashi K; Kato R; Yuki Y; McGhee JR
    J Immunol; 2001 Mar; 166(5):3114-21. PubMed ID: 11207263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A combination of Flt3 ligand cDNA and CpG oligodeoxynucleotide as nasal adjuvant elicits protective secretory-IgA immunity to Streptococcus pneumoniae in aged mice.
    Fukuyama Y; King JD; Kataoka K; Kobayashi R; Gilbert RS; Hollingshead SK; Briles DE; Fujihashi K
    J Immunol; 2011 Feb; 186(4):2454-61. PubMed ID: 21242514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine plasmacytoid pre-dendritic cells generated from Flt3 ligand-supplemented bone marrow cultures are immature APCs.
    Brawand P; Fitzpatrick DR; Greenfield BW; Brasel K; Maliszewski CR; De Smedt T
    J Immunol; 2002 Dec; 169(12):6711-9. PubMed ID: 12471102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respiratory FimA-Specific Secretory IgA Antibodies Upregulated by DC-Targeting Nasal Double DNA Adjuvant Are Essential for Elimination of
    Kataoka K; Kawabata S; Koyanagi K; Hashimoto Y; Miyake T; Fujihashi K
    Front Immunol; 2021; 12():634923. PubMed ID: 33717178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulating dendritic cells to optimize mucosal immunization protocols.
    Williamson E; Westrich GM; Viney JL
    J Immunol; 1999 Oct; 163(7):3668-75. PubMed ID: 10490961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential roles of CCR5(+) CCR6(+) dendritic cells induced by nasal ovalbumin plus Flt3 ligand expressing adenovirus for mucosal IgA responses.
    Fukuyama Y; Tokuhara D; Sekine S; Aso K; Kataoka K; Davydova J; Yamamoto M; Gilbert RS; Tokuhara Y; Fujihashi K; Kunisawa J; Yuki Y; Kiyono H; McGhee JR; Fujihashi K
    PLoS One; 2013; 8(4):e60453. PubMed ID: 23565250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cell-mediated induction of mucosal cytotoxic responses following intravaginal immunization with the nontoxic B subunit of cholera toxin.
    Luci C; Hervouet C; Rousseau D; Holmgren J; Czerkinsky C; Anjuère F
    J Immunol; 2006 Mar; 176(5):2749-57. PubMed ID: 16493030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cell-targeting DNA-based nasal adjuvants for protective mucosal immunity to Streptococcus pneumoniae.
    Kataoka K; Fukuyama Y; Briles DE; Miyake T; Fujihashi K
    Microbiol Immunol; 2017 Jun; 61(6):195-205. PubMed ID: 28463465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen.
    Boyaka PN; Tafaro A; Fischer R; Leppla SH; Fujihashi K; McGhee JR
    J Immunol; 2003 Jun; 170(11):5636-43. PubMed ID: 12759444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-toxic Stx derivatives from Escherichia coli possess adjuvant activity for mucosal immunity.
    Ohmura-Hoshino M; Yamamoto M; Yuki Y; Takeda Y; Kiyono H
    Vaccine; 2004 Sep; 22(27-28):3751-61. PubMed ID: 15315856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD11c(high )dendritic cells are essential for activation of CD4+ T cells and generation of specific antibodies following mucosal immunization.
    Fahlén-Yrlid L; Gustafsson T; Westlund J; Holmberg A; Strömbeck A; Blomquist M; MacPherson GG; Holmgren J; Yrlid U
    J Immunol; 2009 Oct; 183(8):5032-41. PubMed ID: 19786541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Notch-ligand expression by NALT dendritic cells regulates mucosal Th1- and Th2-type responses.
    Fukuyama Y; Tokuhara D; Sekine S; Kataoka K; Markham JD; Irwin AR; Moon GH; Tokuhara Y; Fujihashi K; Davydova J; Yamamoto M; Gilbert RS; Fujihashi K
    Biochem Biophys Res Commun; 2012 Feb; 418(1):6-11. PubMed ID: 22200492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.